CTRI/2026/01/100810尚未招募不适用
A Comparison of the effectiveness and safety of Empagliflozin and Dapagliflozin in type 2 Diabetes mellites patients already on Metformin - A Prospective Comparative study
Self1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2026年2月13日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 80
- 试验地点
- 1
研究概览
简要总结
This is cross sectional ,open lapelled study on changes in bood glucose level, hba1c level,with urinay repord for the presence of bacteria ,pus cells and urinary albumin
研究设计
- 研究类型
- Interventional
- 分配方式
- Other
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 70.00 Year(s)(—)
- 性别
- All
入选标准
- •around 40 to 75 years of age with both sexes.
排除标准
- •Type I diabetes Mellitus.
研究者
Dr Naveen V
Department of pharmacology
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Effectiveness of supplementation of Nefrosave® in Chronic Kidney DiseaseCTRI/2023/12/060567Fourrts India Laboratories Pvt Ltd300
尚未招募
2 期
Effect Of Katankateryadi Kwatha And Shuddha Shilajit In The Management Of Type 2 Diabetes MellitusCTRI/2024/07/070254Ayurvedic and Unani Tibbia College and Hospital60
尚未招募
Phase 3 4
Effect of Sphatika Drava Basti in the Management of Second-Degree Hemorrhoids.CTRI/2026/04/109439Dr. Mohini Kedar74
尚未招募
Unknown
A RANDOMISED ALLOCATED CLINICAL STUDY TO EVALUATE THE ANTI DIABETIC EFFECT OF SULPHUR, PHOSPHORUS AND THUJA OCCIDENTALISCTRI/2024/03/063404Self200
Enrolling By Invitation
4 期
Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 DiabetesType 2 Diabetes MellitusNCT07452913Bahria University110
